HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Farah Abdulla Selected Research

Subcutaneous panniculitis-like T-cell lymphoma

12/2020Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphoma.
8/2012Romidepsin is effective in subcutaneous panniculitis-like T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Farah Abdulla Research Topics

Disease

3Mycosis Fungoides
11/2021 - 01/2019
2Subcutaneous panniculitis-like T-cell lymphoma
12/2020 - 08/2012
1Breast Neoplasms (Breast Cancer)
08/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Lymphoma (Lymphomas)
07/2020
1Sezary Syndrome (Sezary Erythroderma)
12/2019
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2018

Drug/Important Bio-Agent (IBA)

3romidepsin (FK228)FDA Link
12/2020 - 08/2012
1MicroRNAs (MicroRNA)IBA
11/2021
1Doxycycline (Periostat)FDA LinkGeneric
07/2020
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2019

Therapy/Procedure

2Therapeutics
01/2019 - 01/2018
1Metastasectomy
08/2022
1Cell Transplantation
01/2021